What does this research mean for the field?

Women and non-White patients with obstructive hypertrophic cardiomyopathy are less likely to receive advanced therapies despite similar short-term outcomes, and experience higher rates of discharge to skilled nursing facilities. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research examines national trends in cardiovascular prosthetic complications and associated mortality over two decades.

April 26, 2026Journal of the Society for Cardiovascular Angiography & Interventions0 citationsOpen Access

E-74 | Two Decades of Device-Related Mortality: National Trends in Cardiovascular Prosthetic Complications in the United States (1999 - 2020)

RKReza Khademi SSSaeed Shoar

Key Result

Women and non-White patients with obstructive HCM were less likely to receive advanced therapies despite similar short-term outcomes, with higher skilled nursing discharge (11.4% vs 6.6%, P<0.001).

Key Points

This research examines national trends in cardiovascular prosthetic complications and associated mortality over two decades.
Analyzed national data from 1999 to 2020 on device-related mortality and complications in cardiovascular patients.
Focused on demographics, specifically women and non-White individuals with obstructive hypertrophic cardiomyopathy (HCM).
Women and non-White patients were significantly less likely to receive advanced therapies despite having similar outcomes (38.4% vs 33%, P < 0.001).
Discharge rates to skilled nursing facilities were higher for the groups analyzed (11.4% vs 6.6%, P < 0.001).

Structured PICO

Population

Individuals in the United States with deaths attributed to complications of cardiac and vascular prosthetic devices, implants, and grafts (identified using ICD-10 code T82) from 1999 to 2020

Outcome

Mortality attributed to complications of cardiac and vascular prosthetic devices, implants, and graftshard clinical

Device-related mortality has declined significantly in older adults over the past two decades, but remains stagnant in younger patients, indicating a need for improved long-term device durability.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

4% vs 33%, P < 0.001) and discharge to skilled nursing (11.4% vs 6.6%, P < 0.001).Conclusions: Women and non-White patients with obstructive HCM were less likely to receive advanced therapies despite similar shortterm outcomes.These findings underscore persistent inequities in access to specialized HCM care and highlight the need for targeted referral strategies.

KI fragen

Bookmark

View Full Paper